Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
about
Increased prevalence of Methanosphaera stadtmanae in inflammatory bowel diseasesMaintaining tissue homeostasis: dynamic control of somatic stem cell activityIntestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel diseaseCentral role of gimap5 in maintaining peripheral tolerance and T cell homeostasis in the gutToxoplasma gondii soluble tachyzoite antigen triggers protective mechanisms against fatal intestinal pathology in oral infection of C57BL/6 miceLoss of TMF/ARA160 protein renders colonic mucus refractory to bacterial colonization and diminishes intestinal susceptibility to acute colitisProkaryotes Versus Eukaryotes: Who is Hosting Whom?MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5.The GTPase-activating protein GIT2 protects against colitis by negatively regulating Toll-like receptor signaling.Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease.The gut microbiota elicits a profound metabolic reorientation in the mouse jejunal mucosa during conventionalisation.Inside the mucosal immune systemTargeted disruption of MCPIP1/Zc3h12a results in fatal inflammatory disease.Relevance of commensal microbiota in the treatment and prevention of inflammatory bowel disease.Longitudinal study of circulating protein biomarkers in inflammatory bowel disease.Probiotic foods: can their increasing use in India ameliorate the burden of chronic lifestyle disorders?The potter's wheel: the host's role in sculpting its microbiota.MicroRNA-193a-3p Reduces Intestinal Inflammation in Response to Microbiota via Down-regulation of Colonic PepT1The gut microbiome: scourge, sentinel or spectator?B cell-intrinsic MyD88 signaling prevents the lethal dissemination of commensal bacteria during colonic damage.Intestinal microbiota: shaping local and systemic immune responses.The role and pathophysiological relevance of membrane transporter PepT1 in intestinal inflammation and inflammatory bowel disease.Regulatory role of suppressive motifs from commensal DNA.Multifactorial patterns of gene expression in colonic epithelial cells predict disease phenotypes in experimental colitis.Identification of Potential Biomarkers for Gut Barrier Failure in Broiler Chickens.Intraluminal containment of commensal outgrowth in the gut during infection-induced dysbiosis.Group X Secreted Phospholipase A2 Releases ω3 Polyunsaturated Fatty Acids, Suppresses Colitis, and Promotes Sperm FertilityCD4(+) T-cell subsets in intestinal inflammationCardiolipins Act as a Selective Barrier to Toll-Like Receptor 4 Activation in the Intestine.Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors?Triggers and drivers of autoimmunity: lessons from coeliac diseaseIncreased frequency of intestinal CD4+ T cells reactive with mycobacteria in patients with Crohn's disease[Microbiota and T lymphocytes: the best enemies].Enhanced Mucosal Defense and Reduced Tumor Burden in Mice with the Compromised Negative Regulator IRAK-M.Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.Modeling inflammation and oxidative stress in gastrointestinal disease development using novel organotypic culture systems.CD4 T Cell Dependent Colitis Exacerbation Following Re-Exposure of Mycobacterium avium ssp. paratuberculosis.Changes in enteroendocrine and immune cells following colitis induction by TNBS in rats.Abnormalities in endocrine and immune cells are correlated in dextran‑sulfate‑sodium‑induced colitis in rats.Madecassic acid, the contributor to the anti-colitis effect of madecassoside, enhances the shift of Th17 toward Treg cells via the PPARγ/AMPK/ACC1 pathway.
P2860
Q21090656-565214B1-9A61-4CDB-BBD2-1B2256BAB0A5Q26852586-1EC723F3-58DB-4A21-BC66-C0BB0B623334Q27003192-0F7B7BDD-D375-44A5-A7F2-28682A02B7CBQ27025911-B29E587B-48B0-4BD0-88E8-CABBAF238076Q27305548-00DBB815-0617-4EE8-86E8-78A42AD7B5BFQ28586189-E5F058A7-4EB9-4643-9861-29ECFF5D9761Q28606744-60EA14A4-3F62-410C-8307-671272DED518Q33740585-661FF5CE-ED89-4AC4-A552-916448B93EBFQ33790179-B6373957-D661-4299-AAE9-E1C66AB8E9A8Q34240397-319A71DA-CAC7-48F6-8AEF-09ED6B886436Q34313357-F46486D5-0057-4112-8C48-5F0345648A0AQ34437474-A3A19385-32B6-4B71-A9DC-6D715F0EEF4BQ34659842-12F5EE2A-D65F-4839-ABA1-A80797BC16E9Q34813567-2981A927-6E13-44CB-9439-8F028A76C185Q35032838-CC0BB15F-9525-4F5D-83CD-EF83DC84228BQ35113457-E4629E6E-D39A-4790-B8DD-BA5E596FE672Q35569781-8E1B05BB-A14F-4F0D-B745-2E99F4ECB1F6Q35619815-AD3DB32B-840C-4F95-B75D-0AEB81E03451Q35773512-E42F1764-0A5D-45C9-88B8-015D3CD49337Q35784554-4E348012-0B48-4000-87E9-EE9EDB42CF4EQ35799746-CE607A02-743A-4615-ADAD-0216E10481C3Q35849969-F9807ACD-AD5F-4B83-B45E-BBC06B0DE80DQ36189322-75A139EC-0AFF-49F1-A469-3301814CCBAAQ36333341-25169BE9-4A71-43D2-9337-E5611C7A8F36Q36353243-1C99CB0E-D640-48E8-B870-2258EA404A5AQ36724806-12563F85-19DA-43F1-AC88-98B3324C1DB6Q36727399-52BA6A51-1169-48AB-A4B6-88B62C4A3AF1Q37076943-5A2D0737-A3D3-4F69-9FE5-74266B97901CQ37122290-3F898D46-C216-4106-ACE5-A60E9C8201A4Q37194684-65D76AFE-F61B-4555-B777-1096934FF37FQ37283086-EF22F339-7F7A-4285-AB25-962EBF3718EFQ37290615-29E8C09F-7E5B-427B-83CB-A1E9E7CEAE2FQ37352769-CAB0FFE7-F914-4CA3-A5CE-E02C717E42B1Q37584293-B5757F38-1C72-485C-A43B-AE74CD1762F2Q37677012-CE170131-E562-46AB-98BB-098593921902Q37697913-F92B96D2-555E-4150-A8EE-AA19E3EE0710Q37703077-775724C3-F17D-4257-A24D-D9BA155139DAQ37707717-3EF92F90-1AA1-4D5A-99FE-952777EB0C80Q37707732-094B8829-778C-47D5-84E7-C095CE702E73Q37745452-5B0CB7FC-821B-4C5D-BCF0-DB3A7296A14C
P2860
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
@en
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
@nl
type
label
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
@en
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
@nl
prefLabel
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
@en
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
@nl
P2860
P1433
P1476
Experimental inflammatory bowel disease: insights into the host-microbiota dialog.
@en
P2093
Charles O Elson
Maya Saleh
P2860
P304
P356
10.1016/J.IMMUNI.2011.03.008
P407
P577
2011-03-01T00:00:00Z